{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:02:11Z","timestamp":1791849731368,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,1,15]],"date-time":"2012-01-15T00:00:00Z","timestamp":1326585600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s00404-011-2205-2","type":"journal-article","created":{"date-parts":[[2012,1,16]],"date-time":"2012-01-16T11:37:57Z","timestamp":1326713877000},"page":"1553-1562","source":"Crossref","is-referenced-by-count":49,"title":["Role of antihypertensive therapy in mild to moderate pregnancy-induced hypertension: a prospective randomized study comparing labetalol with alpha methyldopa"],"prefix":"10.1007","volume":"285","author":[{"given":"Shaba N.","family":"Molvi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahida","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram S.","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhat","family":"Jabeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Rauoof","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,15]]},"reference":[{"key":"2205_CR1","doi-asserted-by":"crossref","unstructured":"(2000) Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 183:S1\u2013S22","DOI":"10.1016\/S0002-9378(00)40820-3"},{"issue":"1","key":"2205_CR2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0029-7844(03)00475-7","volume":"102","author":"BM Sibai","year":"2003","unstructured":"Sibai BM (2003) Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 102(1):181\u2013192","journal-title":"Obstet Gynecol"},{"key":"2205_CR3","first-page":"160","volume-title":"Hypertension Primer","author":"EW Seely","year":"2003","unstructured":"Seely EW, Lindheimer MD (2003) Pathophysiology of pre-eclampsia. In: Izzi JL Jr, Black HR (eds) Hypertension Primer, 3rd edn. American Heart Association, Dallas, pp 160\u2013163","edition":"3"},{"issue":"9461","key":"2205_CR4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(05)71003-5","volume":"365","author":"B Sibai","year":"2005","unstructured":"Sibai B, Dekker G, Kupferminc M (2005) Pre-eclampsia. Lancet 365(9461):785\u2013799","journal-title":"Lancet"},{"issue":"9","key":"2205_CR5","first-page":"1245","volume":"157","author":"E Rey","year":"1997","unstructured":"Rey E, LeLorier J, Burgess E et al (1997) Report of the Canadian Hypertension Society Consensus Conference:3. Pharmacological treatment of hypertensive disorders in pregnancy. Can Med Assoc J 157(9):1245\u20131254","journal-title":"Can Med Assoc J"},{"issue":"5","key":"2205_CR6","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1479-828X.2004.00268.x","volume":"44","author":"SA Vreeburg","year":"2004","unstructured":"Vreeburg SA, Jacobs DJ, Dekker GA et al (2004) Hypertension during pregnancy in South Australia, part 2: risk factors for adverse maternal and\/or perinatal outcome\u2014results of multivariable analysis. Aus N Z J Obstet Gynaecol 44(5):410\u2013418","journal-title":"Aus N Z J Obstet Gynaecol"},{"issue":"7","key":"2205_CR7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.5694\/j.1326-5377.2005.tb06730.x","volume":"182","author":"CL Roberts","year":"2005","unstructured":"Roberts CL, Algert CS, Morris JM et al (2005) Hypertensive disorders in pregnancy: a population-based study. Med J Aust 182(7):332\u2013335","journal-title":"Med J Aust"},{"key":"2205_CR8","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1471-0528.1992.tb13818.x","volume":"99","author":"L Duley","year":"1992","unstructured":"Duley L (1992) Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Carribean. Br J Obstet Gynaecol 99:547\u2013553","journal-title":"Br J Obstet Gynaecol"},{"key":"2205_CR9","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/0002-9378(90)91123-T","volume":"163","author":"BM Sibai","year":"1990","unstructured":"Sibai BM, Eclampsia VI (1990) Maternal-perinatal outcome in 254 consecutive cases. Am J Obstet Gynecol 163:1049\u20131054","journal-title":"Am J Obstet Gynecol"},{"key":"2205_CR10","doi-asserted-by":"crossref","unstructured":"ACOG Committee on Practice Bulletins\u2014Obstetrics (2002) ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33 Obstet Gynecol 9(1):159","DOI":"10.1016\/S0029-7844(01)01747-1"},{"issue":"3","key":"2205_CR11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1471-0528.1991.tb13387.x","volume":"98","author":"S Blake","year":"1991","unstructured":"Blake S, MacDonald D (1991) The prevention of the maternal manifestations of preeclampsia by intensive antihypertensive treatment. Br J Obstet Gynecol 98(3):244\u2013248","journal-title":"Br J Obstet Gynecol"},{"issue":"6","key":"2205_CR12","doi-asserted-by":"crossref","first-page":"378","DOI":"10.5694\/j.1326-5377.1991.tb121126.x","volume":"154","author":"AF Phippard","year":"1991","unstructured":"Phippard AF, Fischer WE, Horvath JS et al (1991) Early blood pressure control improves pregnancy outcome in primigravid women with mild hypertension. Med J Aust 154(6):378\u2013382","journal-title":"Med J Aust"},{"issue":"4","key":"2205_CR13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4314\/eamj.v79i4.8872","volume":"79","author":"EM Elhassan","year":"2002","unstructured":"Elhassan EM, Mirghani OA, Habour AB et al (2002) Methyldopa versus no drug treatment in the management of mild pre-eclampsia. East Afr Med J 79(4):172\u2013175","journal-title":"East Afr Med J"},{"issue":"2","key":"2205_CR14","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1471-0528.1990.tb01738.x","volume":"97","author":"PF Plouin","year":"1990","unstructured":"Plouin PF, Breart G, Llado J et al (1990) A randomized comparison of early with conservative use of antihypertensive drugs in the management of pregnancy-induced hypertension. Br J Obstet Gynecol 97(2):134\u2013141","journal-title":"Br J Obstet Gynecol"},{"key":"2205_CR15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0301-2115(99)00113-X","volume":"88","author":"LA Magee","year":"2000","unstructured":"Magee LA, Elran E, Bull SB et al (2000) Risks and benefits of beta receptor blockers for pregnancy hypertension: Overview of the randomized trials. Eur J Obstet Gynecol Reprod Biol 88:15\u201326","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"12","key":"2205_CR16","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1471-0528.1992.tb13698.x","volume":"99","author":"CJ Pickles","year":"1992","unstructured":"Pickles CJ, Broughton PF, Symonds EM (1992) A randomized placebo controlled trial of labetalol in he treatment of mild to moderate pregnancy induced hypertension. Br J Obstet Gynaecol 99(12):964\u2013968","journal-title":"Br J Obstet Gynaecol"},{"key":"2205_CR17","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1136\/bmj.318.7194.1332","volume":"318","author":"LA Magee","year":"1999","unstructured":"Magee LA, Ornstein MP, von Dadelszen P (1999) Management of hypertension in pregnancy. Br Med J 318:1332\u20131336","journal-title":"Br Med J"},{"key":"2205_CR18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.semnephrol.2010.10.007","volume":"31","author":"T Podymow","year":"2011","unstructured":"Podymow T, August P (2011) Antihypertensive drugs in pregnancy. Semin Nephrol 31:70\u201385","journal-title":"Semin Nephrol"},{"key":"2205_CR19","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists Technical Bulletin No. 219 (1996). Hypertension in Pregnancy. Int J Gynecol Obstet 53:175\u2013183","DOI":"10.1016\/S0020-7292(96)90112-5"},{"key":"2205_CR20","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00003081-199909000-00008","volume":"42","author":"WC Mabie","year":"1999","unstructured":"Mabie WC (1999) Management of acute severe hypertension and encephalopathy. Clin Obstet Gynecol 42:519\u2013531","journal-title":"Clin Obstet Gynecol"},{"key":"2205_CR21","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s001340050324","volume":"23","author":"DM Linton","year":"1997","unstructured":"Linton DM, Anthony J (1997) Critical care management of severe pre-eclampsia. Intensive Care Med 23:248\u2013255","journal-title":"Intensive Care Med"},{"key":"2205_CR22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0163-7258(97)82005-0","volume":"74","author":"SM Khedun","year":"1997","unstructured":"Khedun SM, Moodley J, Naicker T et al (1997) Drug management of hypertensive disorders of pregnancy. Pharmacol Ther 74:221\u2013258","journal-title":"Pharmacol Ther"},{"issue":"5","key":"2205_CR23","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3109\/10641968009037147","volume":"2","author":"GD Lamming","year":"1980","unstructured":"Lamming GD, Broughton Pipkin F, Symonds EM (1980) Comparison of the alpha and beta blocking drug, labetalol, and methyl dopa in the treatment of moderate and severe pregnancy-induced hypertension. Clin Exp Hypertens 2(5):865\u2013895","journal-title":"Clin Exp Hypertens"},{"key":"2205_CR24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0020-7292(95)02351-C","volume":"49","author":"AM El-Qarmalawi","year":"1995","unstructured":"El-Qarmalawi AM, Morsy AH, Al-Fadly A et al (1995) Labetalol vs methyldopa in the treatment of pregnancy-induced hypertension. Int J Gynecol Obstet 49:125\u2013130","journal-title":"Int J Gynecol Obstet"},{"issue":"2","key":"2205_CR25","first-page":"133","volume":"3","author":"SF Al Damluji","year":"1982","unstructured":"Al Damluji SF, Al Khalidi A, Shaarbaf H (1982) A controlled comparison of the antihypertensive effects of labetalol and methyldopa. Pharmatherapeutica 3(2):133\u2013139","journal-title":"Pharmatherapeutica"},{"issue":"9","key":"2205_CR26","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1471-0528.1988.tb06571.x","volume":"95","author":"PF Plouin","year":"1988","unstructured":"Plouin PF, Breart G, Maillard F, Papiernik E, Relier JP (1988) Comparison of antihypertensive efficacy and prenatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial. Br J Obstet Gynaecol 95(9):868\u2013876","journal-title":"Br J Obstet Gynaecol"},{"key":"2205_CR27","unstructured":"Magee LA, Duley L (2003) Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev (3):CD002863"},{"key":"2205_CR28","doi-asserted-by":"crossref","unstructured":"Abalos E, Duley L, Steyn DW, et al (2001) Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev (2):CD002252","DOI":"10.1002\/14651858.CD002252"},{"key":"2205_CR29","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1471-0528.1998.tb09971.x","volume":"105","author":"P Saudan","year":"1998","unstructured":"Saudan P, Brown MA, Buddle ML et al (1998) Does gestational hypertension become pre-eclampsia? Br J Obstet Gynaecol 105:1177\u20131184","journal-title":"Br J Obstet Gynaecol"},{"key":"2205_CR30","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1067\/mob.2001.112905","volume":"184","author":"JR Barton","year":"2001","unstructured":"Barton JR, O\u2019Brien JM, Bergauer NK et al (2001) Mild gestational hypertension remote from term: progression and outcome. Am J Obstet Gynecol 184:979\u2013983","journal-title":"Am J Obstet Gynecol"},{"key":"2205_CR31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/10641950601147952","volume":"26","author":"GK Davis","year":"2007","unstructured":"Davis GK, Mackenzie C, Brown MA et al (2007) Predicting transformation from gestational hypertension to preeclampsia in clinical practice: a possible role for 24 hour ambulatory blood pressure monitoring. Hypertens Pregnancy 26:77\u201387","journal-title":"Hypertens Pregnancy"},{"key":"2205_CR32","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/01.AOG.0000151116.84113.56","volume":"105","author":"JN Martin Jr","year":"2005","unstructured":"Martin JN Jr, Thigpen BD, Moore RC, Rose CH, Cushman J, May W (2005) Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol 105:246\u2013254","journal-title":"Obstet Gynecol"},{"key":"2205_CR33","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1701-2163(16)32776-1","volume":"30","author":"LA Magee","year":"2008","unstructured":"Magee LA, Helewa M, Moutquin JM, van Dadelszen P, The Hypertension Guideline Committee (2008) Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. SOGC Clinical Practice Guideline, No. 206. J Obstet Gynaecol Can 30:S1\u2013S48","journal-title":"J Obstet Gynaecol Can"},{"key":"2205_CR34","doi-asserted-by":"crossref","first-page":"360","DOI":"10.5694\/j.1326-5377.1996.tb125017.x","volume":"165","author":"MA Brown","year":"1996","unstructured":"Brown MA, Buddle ML (1996) Hypertension in pregnancy: maternal and fetal outcomes according to laboratory and clinical features. Med J Aust 165:360\u2013365","journal-title":"Med J Aust"},{"issue":"1","key":"2205_CR35","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1471-0528.1989.tb01574.x","volume":"96","author":"CJ Pickles","year":"1989","unstructured":"Pickles CJ, Symonds EM, Broughton PF (1989) The fetal outcome in a randomized double blind controlled trial of labetalol versus placebo in pregnancy induced hypertension. Br J Obstet Gynaecol 96(1):38\u201343","journal-title":"Br J Obstet Gynaecol"},{"issue":"7989","key":"2205_CR36","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0140-6736(76)90597-3","volume":"2","author":"CW Redman","year":"1976","unstructured":"Redman CW (1976) Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet 2(7989):753\u2013756","journal-title":"Lancet"},{"issue":"1","key":"2205_CR37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0020-7292(87)90181-0","volume":"25","author":"C Weitz","year":"1987","unstructured":"Weitz C, Khouzami V, Maxwell K, Johnson JW (1987) Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study. Int J Gynecol Obstet 25(1):35\u201340","journal-title":"Int J Gynecol Obstet"},{"issue":"2","key":"2205_CR38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0378-3782(01)00181-5","volume":"64","author":"JG Ray","year":"2001","unstructured":"Ray JG, Burrows RF, Burrows EA et al (2001) MOS HIP: McMaster outcome study of hypertension in pregnancy. Early Hum Dev 64(2):129\u2013143","journal-title":"Early Hum Dev"},{"key":"2205_CR39","doi-asserted-by":"crossref","unstructured":"Abalos E, Duley L, Steyn D, Henderson-Smart D (2007) Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev CD002252","DOI":"10.1002\/14651858.CD002252.pub2"},{"key":"2205_CR40","first-page":"137","volume":"81","author":"H Lardoux","year":"1988","unstructured":"Lardoux H, Blazquez G, Leperlier E, G\u00e9rard J (1988) Randomized, comparative study on the treatment of moderate arterial hypertension during pregnancy: methyldopa, acebutolol, labetalol. Arch Mal Coeur Vaiss 81:137\u2013140","journal-title":"Arch Mal Coeur Vaiss"},{"issue":"6495","key":"2205_CR41","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/bmj.291.6495.563","volume":"291","author":"ED Gallery","year":"1985","unstructured":"Gallery ED, Ross MR, Gyory AZ (1985) Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa. Br Med J (Clin Res Ed) 291(6495):563\u2013566","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"3","key":"2205_CR42","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/10641950500281134","volume":"24","author":"AS Bryant","year":"2005","unstructured":"Bryant AS, Seely EW, Cohen A et al (2005) Patterns of pregnancy-related hypertension in black and white women. Hypertens Pregnancy 24(3):281\u2013290","journal-title":"Hypertens Pregnancy"},{"issue":"1","key":"2205_CR43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10995-005-0026-2","volume":"10","author":"CD Odell","year":"2006","unstructured":"Odell CD, Kotelchuck M, Chetty VK et al (2006) Maternal hypertension as a risk factor for low birth weight infants: comparison of Haitian and African-American women. Maternal Child Health J 10(1):39\u201346","journal-title":"Maternal Child Health J"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-011-2205-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-011-2205-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-011-2205-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T21:46:48Z","timestamp":1593553608000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-011-2205-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,15]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["2205"],"URL":"https:\/\/doi.org\/10.1007\/s00404-011-2205-2","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,15]]}}}